Q&A and closing remarks.
Congress Presentation
About the speaker
Professor Martin Cowie
5 more presentations in this session
Expanding the evidence for rivaroxaban in Atrial Fibrillation (AF) patients with comorbidites including Heart Failure (HF): from Randomized Controlled Trials (RCT) to Real World Evidence (RWE).
Speaker: Professor M. Cowie (Cambridge, GB)
Options in thrombosis prevention and vascular health – What’s on the horizon?
Speaker: Professor K. Fox (Edinburgh, GB)
Broadening the evidence base for rivaroxaban in heart failure.
Speaker: Professor B. Greenberg (San Diego, US)
Exploring new frontiers: is it time for a comorbidity-based approach in heart failure?
Speaker: Doctor R. Mentz (Durham, US)
Access the full session
Management of co-morbidities in heart failure - Exploring new frontiers
About the event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
29 April - 2 May 2017
ESC 365 is supported by
